Insights for life sciences businesses: Funding strategies

Life sciences funding has slowed dramatically in recent months. Diminished venture capital investment, negligible IPO activity and a substantial fall in the value of biotechnology M&A transactions have left many life sciences companies at the brink of crisis. But while securing funding has become more challenging, the long-term prospects for the sector remain quite strong due to unflagging demand for innovative therapies and technologies.

Insights for Life Sciences: Funding strategies offers ideas and recommendations to help life sciences executives develop effective short- and long-term commercial and investment strategies. The white paper provides an overview a range of issues:

• Current funding trends
• Increasingly sharp investor focus on individual projects, programs and products
• Importance of aligning with the right commercial partners
• Deal-term trends
• Alternative funding sources, such as government programs and hybrid public-private offerings

Download this white paper to learn more about how life sciences companies can enhance the likelihood of their success securing funding now and in the future.